Considering the relevance of the NLRP3 inflammasome in AD progression and its dependence on IRE1α endonuclease, it is tempting to speculate that IRE1α activation in CNS-resident myeloid cells may contribute to the development of AD (79–84). Here, ERN1 is linked to Alzheimer disease.